Gut-focused hypnotherapy for children and adolescents with irritable bowel syndrome

Objective Severe irritable bowel syndrome (IBS) in school children and adolescents often leads to stigmatisation, social withdrawal, disrupted education and psychological distress. While there are few effective treatment options for IBS in this age group, gut-focused hypnotherapy (GFH) has shown promise in several trials. Unfortunately, GFH is not widely available, and clinical data outside of trials are scarce. Here, we evaluated outcomes from GFH in patients with IBS, aged <= 18 years, from a tertiary referral centre. Design/Method Consecutive patients aged <= 18 years with severe IBS received 12 sessions of GFH, at weekly intervals, using the Manchester Protocol. Clinical outcomes data, including IBS Symptom Severity Score (IBS-SSS), Hospital Anxiety and Depression Scale (HADS), Non-colonic Symptom Score and Quality-of-Life (QoL) score, were collected prospectively, and compared pre-GFH and post-GFH. Clinical response was defined as >= 50 point reduction in IBS-SSS. Results 32 young patients fulfilling Rome III diagnostic criteria for IBS (median age 16 (range 8-18) years, n=23/32 (72%) female individuals) completed GFH. At baseline, the mean duration of IBS was 5.9 +/- 0.9 years, and the mean IBS-SSS was 313 +/- 14. After GFH, 28/32 (88%) responded, with a mean overall reduction in IBS-SSS -159 +/- 16 (p<0.0001), and 24/32 (75%) achieved >= 30% reduction in abdominal pain scores. GFH also improved: non-colonic symptoms (p<0.0001), HADS-anxiety (p<0.0001), HADS-depression (p=0.0002) and QoL Scores (p<0.0001). Conclusion GFH is highly effective in children and adolescents with IBS. Early intervention with GFH in childhood IBS may reduce the subsequent burden of this problem in adults.

Automated summary

The study found that gut-focused hypnotherapy (GFH) is highly effective in children and adolescents with IBS, significantly improving symptom severity, anxiety, depression, and quality of life. Early intervention with GFH in childhood IBS may reduce the subsequent burden of the disease in adults.